230.82USD-1.50%Mkt Cap: 555.50B USDP/E: 26.77Last update: 2026-05-26
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine…
Industry Peers
Drug Manufacturers - GeneralIndicators:|
Key Statistics
Company
Market Cap555.50B USD
Enterprise Value590.76B USD
Revenue (TTM)96.36B USD
Gross Profit63.94B USD
Net Income (TTM)26.80B USD
Revenue/Share40.02 USD
Last Price230.82 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees138.2K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS4781601046
Valuation
P/E (Trailing)26.77
P/E (Forward)18.23
PEG2.98
EV/EBITDA17.21
EV/Revenue6.13
P/S5.79
P/B6.87
EPS (TTM)8.62
EPS (Forward)12.71
52W Range
149.0480% of range251.71
52W High251.71 USD
52W Low149.04 USD
Profitability
Gross Margin67.88%
Oper. Margin27.41%
EBITDA Margin35.62%
Profit Margin28.46%
ROE32.87%
ROA13.46%
Growth
Revenue Growth9.90%
Earnings Growth-52.90%
Cash Flow & Leverage
Operating CF24.53B USD
CapEx (TTM)5.22B USD
FCF Margin12.98%
FCF Yield2.25%
Net Debt32.94B USD
Net Debt/EBITDA0.96
Balance Sheet
Debt/Equity0.59
Current Ratio1.02
Quick Ratio0.69
Book Value/Sh33.73 USD
Cash/Share9.160 USD
Dividends
Fwd Div Rate5.360 USD
Trail. Div Rate5.200 USD
Div. Yield2.31%
5Y Avg Yield2.77%
Payout Ratio60.25%
Ex-Div DateMay 26, 2026
Pay DateJun 9, 2026
Splits
Last Split2:1
Split DateJun 13, 2001
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)252.96 USD
Target Range155.00 USD – 285.00 USD
# Analysts24
Ownership
Shares Out.2.41B
Float2.40B
Insiders0.05%
Institutions77.01%
Short Interest
Short Ratio2.9d
Short % Float1.03%
Short % Out.0.93%
Shares Short22.35M
Short (prev mo.)22.27M
Technical
SMA 50233.52 (-1.2%)
SMA 200210.43 (+9.7%)
Beta0.26
S&P 52W Chg28.31%
Avg Vol (30d)7.67M
Avg Vol (10d)7.94M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—